Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | GALR3 | O60755 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.38 |
| ▸ | BCL2 | P10415 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL789209 | 0.84 | ERN1 (0.52) | ERN1ALOX15HPGDCASP1CES2 | |
| SCHEMBL15660236 | 0.81 | ERN1 (0.44) | ERN1ALOX15HPGDCASP1CES2 | |
| SCHEMBL8205 | 0.80 | PDPK1 (0.43) | — | |
| SCHEMBL472482 | 0.80 | GABRA1 (0.50) | ERN1ALOX15HPGDALOX12ALDH1A1 | |
| SCHEMBL5738944 | 0.79 | HSP90AA1 (0.41) | ERN1ALOX15HPGDALDH1A1TSHR | |
| SCHEMBL933119 | 0.79 | TYR (0.58) | ALOX15ALDH1A1HTTTSHRGFER | |
| SCHEMBL30513627 | 0.79 | TYR (0.58) | ALOX15ALDH1A1HTTTSHRGFER | |
| SCHEMBL6739825 | 0.78 | KDM4E (0.38) | ERN1ALOX15ALDH1A1 | |
| SCHEMBL1569775 | 0.78 | CA3 (0.46) | ALOX15HTTCA9TYR | |
| SCHEMBL4573203 | 0.77 | ALOX15 (0.38) | ERN1ALOX15HPGDCASP1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112218872-B | Tungsten (VI) compounds with thermally activated delayed fluorescence or phosphorescence for organic light emitting devices | 香港大学 | 2023-11-03 | — | — | CN | claimed |
| US-20210380616-A1 | TUNGSTEN (VI) COMPOUNDS WITH THERMALLY ACTIVATED DELAYED FLUORESCENCE OR PHOSPHORESCENCE FOR ORGANIC LIGHT-EMITTING DEVICES | THE UNIVERSITY OF HONG KONG (CN) | 2021-12-09 | — | — | US | claimed |
| CN-112218872-A | Tungsten (VI) compounds with thermally activated delayed fluorescence or phosphorescence for organic light emitting devices | 香港大学 | 2021-01-12 | — | — | CN | claimed |
| WO-2019228512-A1 | TUNGSTEN (VI) COMPOUNDS WITH THERMALLY ACTIVATED DELAYED FLUORESCENCE OR PHOSPHORESCENCE FOR ORGANIC LIGHT-EMITTING DEVICES | THE UNIVERSITY OF HONG KONG (CN) | 2019-12-05 | — | — | WO | claimed |
| WO-2024025953-A2 | THERAPEUTIC USES OF UROLITHIN DERIVATIVES | VANDRIA SA (CH) | 2024-02-01 | — | — | WO | disclosed |
| EP-3790865-A1 | PHENYL SUBSTITUTED PYRAZOLES AS MODULATORS OF RORYT | Janssen Pharmaceutica NV (BE) | 2021-03-17 | — | — | EP | disclosed |
| EP-3774777-A2 | MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | Arvinas Operations, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| EP-3774789-A1 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | Arvinas Operations, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019243999-A1 | PHENYL SUBSTITUTED PYRAZOLES AS MODULATORS OF RORYT | JANSSEN PHARMACEUTICA NV (BE) | 2019-12-26 | — | — | WO | disclosed |
| WO-2019195201-A1 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. (US) | 2019-10-10 | — | — | WO | disclosed |
| EP-3365061-A1 | AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS | Axovant Sciences GmbH (DE) | 2018-08-29 | — | — | EP | disclosed |
| WO-2018102554-A1 | CLEAVABLE NUCLEOTIDE ANALOGS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-06-07 | — | — | WO | disclosed |
| WO-2010027500-A1 | AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS | SIGNAL PHARMACEUTICALS, LLC (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010019905-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 PHARMACEUTICALS, LLC (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2009102633-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-20 | — | — | WO | disclosed |
| WO-2009039127-A1 | URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C | ABBOTT LABORATORIES (US) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009039134-A1 | ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009001127-A1 | CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS | ASTRAZENECA AB (SE) | 2008-12-31 | — | — | WO | disclosed |
| EP-0918768-A1 | AROMATIC AMIDINE DERIVATIVES USEFUL AS SELECTIVE THROMBIN INHIBITORS | C & C Research Laboratories (KR) | 1999-06-02 | — | — | EP | disclosed |
| WO-1997045424-A1 | AROMATIC AMIDINE DERIVATIVES USEFUL AS SELECTIVE THROMBIN INHIBITORS | C & C RESEARCH LABORATORIES (KR) | 1997-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380616-A1 | TUNGSTEN (VI) COMPOUNDS WITH THERMALLY ACTIVATED DELAYED FLUORESCENCE OR PHOSPHORESCENCE FOR ORGANIC LIGHT-EMITTING DEVICES | OCIAD2, TRPC6, NUDT1 | ERN1 2456/4885ALOX15 1285/4885HPGD 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.